London, England, United Kingdom
Dilbagh is a UK-registered independent prescribing pharmacist with extensive experience across clinical practice, clinical trials & pharmaceutical industry at leadership & management levels. Holding a First-Class MPharm from the University of Reading and a Distinction-grade PG Dip GPP from UCL, he has proven expertise in medical affairs, clinical leadership and strategic collaboration. As a Medical Lead in Oncology and Gastroenterology and a Final Medical Signatory, he excels in RWE data generation, KOL engagement, medical education and cross-functional collaboration to address unmet needs, drive patient outcomes & business success. Clinical Experience: • Royal Brompton Hospital: Experience in cardiology and respiratory medicine, including cystic fibrosis. • King’s College Hospital: Led renal & dialysis units & worked across multiple therapy areas in medicine. Completed an audit on antimicrobial prescribing in neonates and a clinical trials secondment in Haematology/Oncology & Hepatology. • Harefield Hospital: Specialist Pharmacist in Cardiothoracic Transplantation & VADs, focusing on immunosuppression & anti-infective therapies. Led a Quality Improvement Project on Home IV Antibiotics. • Imperial College London (Charing Cross Hospital): Lead Specialist Medicine Pharmacist in Diabetes, Endocrinology, Gastroenterology & Respiratory. Led diabetes & lipid clinics, growth hormone therapy & NET services while managing high-cost drug funding and guideline development. Pharmaceutical Industry Experience: Final Medical Signatory w/ leadership across multiple therapy areas, shaping pipeline strategy & pre-launch activities. • Solid Organ Transplantation (Renal & Liver): Led pipeline development, RWE studies, KOL engagement and clinical trial design. • Rare Diseases: Sole UK Medical Advisor, collaborating across Europe & global teams. • Immunology & Neurosciences: Medical Lead for Rheumatology (AxSpA), driving medical & digital strategy, congress activities and material approvals. • Oncology & Radioligand Therapies: Led pipeline strategy & KOL engagement for oncology assets, including radioligand therapies in NETs, Prostate, Breast & Lung Cancers. • Gastroenterology: Medical Lead for IBD & microbiome, overseeing strategy, RWE and cross-functional collaborations. Including HTA submissions. • Uro-Oncology: Led medical strategy in prostate & bladder cancers, supporting clinical trials & investigator-initiated studies. Line management of MSL team. Dilbagh’s clinical expertise & strategic leadership drive innovation & success across multiple therapies.
Country head of medical affairs speciality medicine: Gene therapy/ATMP Oncology, Urology & Gastroenterology (including pipeline) Therapy areas include: Prostate Cancer, Bladder Cancer, Inflammatory Bowel Disease (IBD), Microbiome & Paediatric Urology. MSL field excellence lead Line management of speciality brand MSLs, medical advisors & signatory team. Final medical signatory for speciality brands. Responsible for medical launch strategy, medical plans, KOL management, KEE engagement plans, RWE/data generation, medical education, digital innovation & scientific communication/congresses. Cross-functional collaboration with leadership team, global medical affairs, regulatory, compliance, pharmacovigilance, patient safety, quality, medicines information, finance, digital execution excellence, marketing, sales & market access teams. Active participant in the Ferring UKIE leadership team. Role includes approver in meeting such as UKIE data generation/IIS committee, & UKIE grants committee. Writer of company SOPs & guidelines. Medical training & validation of internal & external stakeholders.
U.K. Medical Affairs Lead for neuroendocrine tumours (NETs) & all radiosensitive cancer indications in Pipeline (Breast, small cell lung cancer, prostate & glioblastomas). Nuclear medicine, targeted radioligand therapies and precision imaging radioligands for oncology. Final medical signatory. Medical affairs lead. Line management & mentorship of junior scientific advisors & medical interns.
Lead for Rheumatology (AxSpA) & Transplantation within Immunology Franchise. Experience across in-line & pipeline portfolio. Medical review & approval of non-promotional & promotional materials. Internal Medical sign off & co-creation of projects & strategy with cross-functional teams. Real World Evidence & Data generation with aim to target unmet needs of patients & HCPs. Abstract & publication planning with scientific communications team. Knowledge of ABPI code & internal SOPs to ensure compliance across all activities. Experience with core medical affairs activities such as congress planning, stakeholder mapping & external engagement, advisory boards, educational events/perceptionships & sponsorships. Digital expertise in non-promotional educational content creating. Knowledge & experience with AI/Machine Learning to aid diagnosis & early identification of disease/tools to optimise care e.g. predictive biomarkers.
Medical Advisor for U.K. Lead Specialist Pharmacist. GPhC Registered. Member of the Rare Disease Unit Region Europe, full responsibility for U.K. Medical expert for autoinflammatory diseases & transplantation. Responsible for the regional and local medical strategy Contributing to development of Region Europe medical strategy & tactical plan Providing medical strategic input, medical & scientific field insights, medical support to Market Access, Patient Access, local and regional Marketing, Business Ops & ClinOps in countries of responsibility
A Novartis company - role undertaken as part of Novartis UK employment. Adacap is an innovative leader in nuclear medicine and targeted radioligand therapy for oncology indications. Medical affairs manager role - managing neuroendocrine tumours portfolio & radiosensitive cancers pipeline indications (breast cancer, glioblastomas, small cell lung cancer & prostate cancer) Final medical signatory. Collaboration with marketing leads, patient advocacy & government affairs specialists. Mentor & management of junior scientific advisors & medical affairs interns.
Working in the NHS since 2015 (Roles: Pre-Registration Pharmacist, Rotational Core Training Pharmacist (Residential B6 posts at Royal Brompton & King’s College Hospital), Senior Clinical Trials/Hepatology Pharmacist, Specialist Transplantation & ICU Pharmacist (B7 speciality trainee posts), Lead Pharmacist Medicine (8a directorate lead post)